Probiotics are amazing. Not only do they improve our GI tract, they also balance the immune system, fight infections and allergies and improve our mood and cognitive function. Read on to learn how these “good bacteria” enhance our mood, combat stress and help with obesity and diabetes.

What are Probiotics?

Gut Microbiota

At birth, the sterile human gut is immediately colonized with several types of microorganisms from both the mother and the environment. By the time they reach one year of age, each individual develops a unique bacterial profile (R).

It is estimated that only 10% of the cells in the human body actually belong to the body itself. The overwhelming majority of the cells consist of the diverse microbiota of nonpathogenic bacteria, 1-2 kg of them living in the gut alone (R).

Gut microbiota consists of at least 1014 bacteria (R), comprised of at least 160 different bacterial species from a pool of 1000-1150 (R).

Gut microbiota includes ~30 species of Bifidobacterium, 52 species of Lactobacillus, and others, such as Streptococcus and Enterococcus (R).

The genome of the entire gut microbiota named as “microbiome” exceeds the human nuclear genome by at least 100 times (R).

Human gut microorganisms are strongly involved in diverse metabolic, nutritional, physiological, and immunological processes (R). They play an important role in energy homeostasis and through the microbe–gut–brain axis (R) they impact our mood and cognitive abilities. They also stimulate the immune response, prevent pathogenic and opportunistic microbes/bacteria, and produce vitamins such as B and K (R).

Diet can exert a profound effect on the gut microbiota profile, and people in different parts of the world have different bacterial profiles (R). For example, there is an association of Bacteroides and high animal fat or protein diets, while Prevotella is associated with a high carbohydrate diet (R).

Changes in microbiota composition can increases susceptibility to infections, immune disorders, inflammation, oxidative stress and insulin resistance (R).


Probiotic bacteria are live microorganisms known as “friendly gut bacteria” which when present and/or administered in adequate amounts can have potential health benefits (R).

The term “probiotic” comes from the Greek term ‘for life’ (R).

Probiotics have been regarded as beneficial since ancient times (particularly lactic acid bacteria – Lactobacilli and Bifidobacteria), but they came into spotlight in the late 1800s and early 1900s, when it was proposed that consuming yogurt containing Lactobacillus would decrease toxin-producing bacteria in the gut and increase longevity (R).

Naturally occurring probiotic bacteria exist in fermented food products such as yoghurt, kefir, sauerkraut, cabbage kimchee and soy bean based miso and natto (R).

The most common probiotic strains belong to the species Lactobacillus and Bifidobacterium, followed by the genera Streptococcus, Enterococcus, Propionibacterium, Bacillus, and Escherichia. In addition, some yeast species are used as probiotics, for example, S. boulardii and S. cerevisiae (R,R).

Probiotics can enhance the immune system, improve the skin’s function, enhance resistance against allergens, and decrease body pathogens (R). They have anti-inflammatory effects, they improve blood lipid profile and glucose tolerance (R), and lower blood pressure and the BMI (R).

Note that in clinical studies, probiotic mixtures are often demonstrated to be better than a single strain for improving indigenous microflora (R).


Prebiotics are specific carbohydrates, such as polysaccharides, fructans, and inulins, that can exert beneficial effects on the composition and metabolic activities of gut microorganisms. A diet high in inulin and related fibers, for example, has been shown to increase Bifidobacteria (R).


A prebiotic and probiotic combination is referred to as a Synbiotic, when the net health benefit is synergistic (R).

Health Benefits of Probiotics

1) Probiotics can Increase Vitamin Levels

Daily consumption of L. acidophilus significantly improved vitamin B12 and folate levels in children (R).

Taking L. reuteri increased blood levels of vitamin D3 by 25.5% in a Canadian study (R).

L. reuteri isolated from sourdough, has been shown to produce cobalamin (vitamin B12)(R), while L. plantarum isolated from raw cow milk can produce riboflavin (B2) and folate (B9) (R).

Folate-rich fermented milk produced by high-folate-producing S. thermophilus increases hemoglobin levels in mice (R).

L. cerevisiae is a also a rich dietary source of folate (R,R).

2) Probiotics can Increase Iron Levels

Iron deficiency in young women in south India was associated with low levels of Lactobacilli (R).

L. plantarum was shown to increase iron absorption by women: from a fruit drink by approximately 50% (R) and from an oat base by over 100% (R).

Preschool children supplemented with L. acidophilus exhibited higher red blood cell status (R), and a significant reduction in the prevalence of anemia (R).

Milk with B. animalis ssp. lactis and prebiotic oligosaccharides reduced the risk of being anemic and iron deficient by 45% and increased weight gain by 0.13 kg/year in 1-4-year-old children (R).

3) Probiotics can Increase Minerals

L. helveticus increased blood calcium level in elderly volunteers (R), and postmenopausal women (R).

L. fermentum was shown to increase the bioavailability of calcium, phosphorus, and zinc in fermented goat milk (R), while fermented milk containing L. plantarum showed higher calcium retention (R).

By degrading phytate, S. cerevisiae was shown to improve the absorption of iron, zinc, magnesium and phosphorus (R,R).

4) Probiotics Act as Antioxidants

L. casei, L. helveticus, L. fermentum, B. bifidum and B. subtilis exhibit antioxidant properties (R,R,R,R,R,R).

Similarly, B. animalis and L. lactis effectively scavenges free radicals and significantly enhance the activities of antioxidative enzymes in mice (R,R).

A B. subtilis signal molecule induces the heat shock protein Hsp27 in mammalian cells, which protects intestinal cells against oxidant-mediated tissue damage (R).

5) Probiotics May be Neuroprotective

The probiotic you want: C. butyricum

B. breve and C. butyricum increase BDNF in rats and mice, respectively (R).

C. butyricum, furthermore, restores butyrate in the brain, reduces neuronal cell death, and significantly attenuates cognitive dysfunction and histopathological changes in mice with vascular dementia (R).

C. butyricum also exerts neuroprotective effects against ischemia/reperfusion injury in mice (R), and attenuates cognitive impairment, cell damage and neuronal death in diabetic mice with cerebral ischemia/reperfusion injury (R).

6) Probiotics May Improve Cognitive Function

Try: L. helveticus

Gut probiotics play a major role in the bidirectional communication between the gut and the brain (R), referred to as the “microbiota-gut-brain” axis. It is now generally accepted that microbiota can affect behavior and modulate cognitive function (R).

Probiotics improve both spatial and non-spatial memory (R). Probiotics administration considerably improved the impaired spatial memory and efficiently reversed deteriorated brain in diabetic rats (R,R).

Germ-free mice display deficits in non-spatial and working memory. Also, mice that were exposed to gut bacterial infection and stress exhibited memory deficits, while probiotic treatment 7 days before and during the infection prevented cognitive dysfunction (R).

B. longum improved learning and memory (R), while L. helveticus improved scopolamine-induced cognitive impairments, and object recognition memory (R) in mice.

L. helveticus also improved stress-induced cognitive dysfunction (R) and restored cognitive function in rats with neuroinflammation (R).

L. plantarum was shown to improve learning and memory in rats with vascular dementia, by acting as a blood pressure-lowering and neuroprotective agent (R).

Finally, L. casei  potentiates the effect of proanthocyanidins extracted from lotus seedpod, and ameliorates memory impairments in mice (R).

7) Probiotics Improve our Mood

The vast assemblage of microorganisms in our intestines may have a major impact on our state of mind (R). Gut microorganisms are able to produce and deliver such neuroactive substances as serotonin and gamma-aminobutyric acid (GABA) (R).

A multispecies probiotic containing B. bifidum, B. lactis, L. acidophilus, L. brevis, L. casei, L. salivarius, and L. lactis reduces cognitive reactivity to sad mood in non-depressed individuals, which was largely accounted for by reduced rumination and negative thoughts (R).

An inverse association between constipation and feelings of calmness, elatedness and agreeableness was found, i.e. frequent constipation was associated with a poorer mood state. A probiotic multivitamin compound significantly improved the general condition of those who participated in the study with a 41% improvement in stress, a 29% decrease in the prevalence of infection and a 91% reduction in GI discomfort (R).

Probiotic yogurt improved the mood of those with an initially poor mood (R).

Consuming a probiotic yogurt or a multispecies probiotic capsule for six weeks had beneficial effects on the mental health biomarkers of petrochemical workers (R).

8) Probiotics Combat Depression

A correlations was found between human microbiota and depression. Probiotics significantly decreased depression scores in both healthy individuals and patients with major depressive disorder under 60 years of age (R).

L. helveticus and B. longum reduced depression in healthy volunteers when they were taken regularly (R).

A mix of L. acidophilus, L. casei and B. bifidum decreased depression, and in addition lowered insulin levels, insulin resistance and hs-CRP and increased glutathione levels in patients with major depressive disorder (R).

B. infantis, L. helveticus or L. rhamnosus improve depression in rats (R,R).

Chronic administration of B. infantis protects rats from depressive symptoms caused by stress induced through maternal separation (R).

9) Probiotics Reduce Anxiety

Try L. helveticus and/or B. longum

Infecting healthy mice with pathogenic bacteria stimulates anxiety behaviors within hours of infection suggesting that changes in the gut microbiota can very quickly induce biochemical changes in the brain (R).

L. helveticus and B. longum decreased anxiety and anger/hostility in human volunteers (R).

Probiotic treatment with L. helveticus improved anxiety-like behavior in rats (R,R), and prevented the negative effect of Western-style diet on anxiety and memory in mice (R).

L. rhamnosus (R), L. fermentum (R) and B. longum (R) also reduce anxiety-like behavior in mice.

Chronic ingestion of L. plantarum reduced anxiety-like behaviors in mice, and increased dopamine, and serotonin levels (R,R).

10) Probiotics May Alleviate OCD

L. rhamnosus treatment attenuates mouse OCD-like behaviors (R).

11) Probiotics may Ameliorate Autism

There is a potential role of intestinal microorganisms in the complex pathophysiology of autism spectrum disorder (ASD). Treatment of an autism mouse model with probiotics ameliorated ASD-related traits (R).

In an animal model of social deficits in offspring, L. reuteri was found to be 9X lower. Supplementing with it increased oxytocin levels and significantly improved sociability and preference for social novelty in mice offspring (R).

12) Probiotics May be Beneficial in Schizophrenia

Daily administration of B. longum reduced schizophrenic rearing behavior in mice, decreased the resting level of plasma corticosterone and the ratio of kynurenine to tryptophan (R).

13) Probiotics Combat Stress

Stressed out? Try: L. casei  and/or B. bifidum

L. casei  lowered academic-stress-induced increases in cortisol and the incidence of physical symptoms in students (R).

In stressed rats, L. casei  suppressed blood corticosterone levels (R).

Similarly, when L. casei  was administered to medical students undertaking an authorized nationwide examination to test their response to stress, this bacterium increased serotonin levels, lowered the rate of subjects experiencing common abdominal and cold symptoms and decreased the total number of days students experienced these symptoms (R).

In academically stressed undergraduate students, B. bifidum increased the proportion of healthy days per participant and decreased the percentage of participants reporting cold/flu during the intervention period (R).

Similarly, B. bifidum reduced self-reported stress and stress associated diarrhea/GI discomfort in undergraduate students (R).

14) Probiotics Improve the Sleep-Wake Cycle

L. helveticus-fermented milk significantly improved sleep efficiency in healthy elderly people (R).

In volunteers with insomnia, L. brevis showed a mildly beneficial effect on sleep in subjects with insomnia (R).

Daily voluntary wheel-running and sleep rhythmicity became intensified in mice when heat-killed L. brevis was added to the diet (R).

15) Probiotics can Reduce Weight

Look for: L. rhamnosus and/or L. gasseri

Consuming probiotics can reduce body weight and BMI. A greater effect is achieved in overweight subjects, when multiple species of probiotics are consumed in combination or when they are taken for more than 8 weeks (R).

L. rhamnosus induced weight loss in women, reducing fat mass and circulating leptin concentrations (R).

L. gasseri significantly decreased body weight and visceral and subcutaneous fat areas in adults with obese tendencies (R).

Despite there being no change in behavior or diet, administration of L. gasseri  modestly reduced weight and waist and hip circumference in obese and overweight adults (R).

L. gasseri significantly decreased BMI, abdominal visceral fat, waist and hip circumferences, and body fat mass in healthy Japanese adults. However, constant consumption of this probiotic may be required to maintain this effect (R).

Both L. rhamnosus and L. gasseri  also significantly lowered weight in mice (R,R,R) while L. gasseri  was also shown to reduce body weight in rats (R).

16) Probiotics Combat Obesity

Intestinal microbiota can affect host adiposity and regulate fat storage (R).

Bifidobacteria content was higher in children of normal weight than those who were showing signs of becoming overweight (R). Similarly, the presence of B. animalis was found to be negatively associated with BMI in humans (R,R).

The intake of synbiotics (probiotics + prebiotics) in obese children resulted in a significant reduction in BMI, waist circumference, and some cardiometabolic risk factors, such as TC, LDL-C and TAG (R).

L. acidophilus, B. animalis ssp. lactis and L. casei reduced BMI, fat percentage, and leptin levels in overweight individuals (R).

Daily ingestion of milk containing B. animalis ssp. lactis significantly reduced the BMI, total cholesterol, low-density lipoprotein, and inflammatory markers in humans (R).

A low-calorie diet supplemented with L. plantarum reduced BMI in Russian adults with obesity and hypertension (R).

L. gasseri  prevented abdominal fat accumulation (R), and decreased body weight in adults with obese tendencies (R).

B. breve lowered fat mass and improved GGT and hs-CRP in adults with obese tendencies (R).

L. rhamnosus improved liver parameters in obese children with liver dysfunction noncompliant with lifestyle interventions (R).

L. paracasei  decreases energy/food intake in both human and animal subjects (R).

Oral administration of B. longum, B. bifidum, B. infantis, and B. animalis decreased glucose levels, ameliorated insulin resistance and reduced the expressions of inflammatory adipocytokines in obese mice (R).

B. breve reduced body weight gain and accumulation of visceral fat in a dose-dependent manner, and improved serum levels of total cholesterol, fasting glucose and insulin in a mouse model of diet-induced obesity (R).

C. butyricum reduced fat accumulation in liver and blood, lowered insulin levels and improved glucose tolerance and insulin sensitivity in obese mice. Furthermore, C. butyricum administration ameliorated GI and fat tissue inflammation (R).

Water extract of L. paracasei  reduced body weight in obese rats. It decreased the formation of lipid plaques in the aorta, reduced fat cell size and inhibited fat absorption, thereby reducing fat production (lipogenesis) (R).

NOTE: Although some studies show beneficial effects of L. reuteri in obesity-related symptoms, in one study, this species was associated with obesity in humans (R).

17) Probiotics Reduce Glucose and Improve Insulin Sensitivity

Several studies show that probiotics have a significant effect on lowering fasting blood glucose and insulin in diabetics (R,R).

L. plantarum reduced glucose levels in postmenopausal women (R).

L. casei  improved insulin sensitivity in subjects with metabolic syndrome (R).

Furthermore, long‐term ingestion of L. casei  ameliorated insulin resistance and glucose intolerance in rats fed a high‐fat diet (R), rats with hyperinsulinemia (R),  and obese mice (R).

L. plantarum caused a significant reduction of blood glucose levels in response to insulin in mice on a high-fat-diet (R).

An L. paracasei  symbiotic was shown to improve many aspects of insulin resistance, such as fasting response, hormonal homeostasis, and glycemic control in rats (R).

L. gasseri  increased energy expenditure, reduced blood glucose, improved glucose tolerance, attenuated inflammation (R), and reduced insulin levels in rats (R).

18) Probiotics are Beneficial in Diabetes

Gut microbiota play important roles in the pathogenesis and metabolic disturbances of type 2 diabetes mellitus (T2DM) (R).

Gut microbiota of adults with T2DM is quite different from the microbiota of nondiabetic adults. The content of Bifidobacteria is decreased, whereas Enterococci and Escherichia coli are increased significantly (R).

Probiotics can improve the carbohydrate metabolism, total cholesterol, fasting blood glucose, insulin sensitivity and antioxidant status, and reduce metabolic stress in subjects with T2DM (R,R).

Certain probiotics (L. lactis, Bifidobacteria) secrete an insulin analog (R), and they can modestly improve fasting insulin in people with T2DM (R).

In Humans:

In T2DM patients, L. acidophilus and B. animalis increase good cholesterol (HDL-C) levels and decrease the LDL-C/HDL-C ratio (R). They further significantly decrease fasting blood glucose, and exert antioxidant properties (R).

A synbiotic containing L. acidophilus, L. casei, B. bifidum and inulin decreased fasting plasma glucose, blood insulin concentrations and increased insulin sensitivity in overweight diabetic patients with coronary heart disease. In addition, HLDL-cholesterol levels were increased (R).

Consumption of a synbiotic containing B. coagulans reduced insulin levels, improved blood lipid profile and increased good cholesterol (HDL-C) in type 2 diabetes (T2D) patients (R,R,R).

Similarly, consumption of a synbiotic with B. coagulans improved NO, MDA (R), hs-CRP, uric acid and plasma total GSH levels in diabetic patients (R).

L. acidophilus preserved insulin sensitivity in men with T2DM (R).

Soy milk containing L. plantarum has antioxidative properties and decreases DNA damage in patients with T2DM (R).

Diabetic patients who develop foot ulcers are at more risk of dying prematurely than those without the complication. B. subtilis shows antimicrobial activity against four diabetic foot ulcer bacterial pathogens (R).

Animal studies:

B. animalis ssp. lactis reduces weight gain and fat mass, improves glucose tolerance (R), decreases fasting insulin and blood glucose, and significantly improves insulin tolerance in mice with diabetes (R).

B. bifidum decreased fasting blood glucose and insulin in diabetic rats (R).

B. bifidum can stabilize blood sugar, lower cholesterol levels in serum, and improve metabolic activity in mice (R).

L. brevis decreases glucose levels in diabetic rats (R).

L. gasseri  decreases blood glucose and improves glucose sensitivity in diabetic mice (R).

L. johnsonii  inhibits hyperglycemia, reduces the elevation of blood glucose and glucagon levels in diabetic rats (R), and inhibits insulin resistance in mice (R).

Administration of L. casei  and B. bifidum alone and in combination ameliorated hyperglycemia, dyslipidemia, and oxidative stress in diabetic rats (R).

L. casei  significantly improved glucose intolerance, dyslipidemia, immune-regulatory properties, and oxidative stress in mice with T2D (R).

Treating diabetic mice with inviable L. salivarius reversed gut microbial imbalance, restored mucosal antibacterial protein and lessened endotoxin levels (R).

L. rhamnosus exerts an anti-diabetic effect in mice, with an anti-hyperglycemic effect in several rodent models. L. rhamnosus further improves glucose tolerance and enhances insulin sensitivity (R).

Treatment with L. plantarum favorably regulates blood glucose, hormones, and lipid metabolism in diabetic rats (R).

19) Probiotics Reduce Bad Cholesterol

Daily consumption yogurt containing L. acidophilus after each dinner contributes to a significant reduction in cholesterol (R). However, it was shown that L. acidophilus does not lower blood cholesterol in men and women with normal to borderline high cholesterol levels (R).

A synbiotic product containing L. gasseri  and inulin reduced total blood cholesterol, low-density lipoprotein (LDL)-cholesterol and triglycerides in hypercholesterolemic men and women (R).

Buffalo milk yogurt and soymilk yogurt with B. longum decreased total cholesterol by 50%, LDL- cholesterol by 56%, and triglycerides by 51% (R).

In one study, L. reuteri reduced LDL cholesterol by 11.64%, reduced total cholesterol by 9.14%, non-HDL-cholesterol by 11.30% and apoB-100 by 8.41% (R). In another study, L. reuteri reduced LDL by 8.92% and total cholesterol by 4.81% (R).

6-week supplementation of L. salivarius along with fructooligosaccharide (FOS) significantly reduced total cholesterol, “bad” (LDL) cholesterol, and triglycerides (R).

B. longum reduced total cholesterol, particularly among subjects with moderate hypercholesterolemia (R).

L. fermentum  modestly improved cholesterol in a clinical study (R).

B. coagulans containing symbiotic reduced TAG and VLDL in pregnant women (R), and reduced total blood cholesterol, LDL-cholesterol in a small clinical trial (R,R).

In another study, a combination of bacteria strains more effectively reduced total cholesterol and liver cholesterol compared to individual bacteria strains (R).

B. animalis, B. bifidum and B. longum reduced total cholesterol and LDL-C in children with primary dyslipidemia (R).

Milk fermented with L. acidophilus and B. longum significantly reduced LDL cholesterol in hypercholesterolemic women (R).

In overweight subjects, the administration of capsules with Bifidobacteria, Lactobacilli, and S. thermophilus significantly improved lipid profiles, reducing total cholesterol (TC), triacylglycerols (TAG), and LDL-C levels (R).

See individual probiotic posts for more information and animal studies.

20) Probiotics Increase Good Cholesterol

Probiotics can increase high-density lipoprotein-cholesterol (HDL-C) (R).

In T2DM patients, L. acidophilus and B. animalis increase good cholesterol (HDL-C) levels (R).

A synbiotic containing L. acidophilus, L. casei, B. bifidum and inulin increased HDL-cholesterol in diabetic subjects (R).

A synbiotic shake containing L. acidophilus, B. bifidum and fructo-oligosaccharides significantly increased HDL-C in elderly people with diabetes (R).

6-week supplementation of L. salivarius along with fructooligosaccharide (FOS) significantly increased “good” (HDL) cholesterol in healthy young volunteers (R).

In overweight subjects, Bifidobacteria, Lactobacilli, and S. thermophilus significantly improved HDL-C (R).

B. coagulans increased good cholesterol in diabetic patients (R).

L. plantarum increased “good” (HDL) cholesterol in mice (R).

B. bifidum increased HDL in diabetic rats (R).

21) Probiotics Reduce Blood Pressure

Try: L. helveticus

L. helveticus produces angiotensin-converting enzyme (ACE)-inhibitory peptides that can prevent or control high blood pressure (R).

L. helveticus fermented milk has a BP-lowering effect in hypertensive subjects (R,R).

Daily ingestion of the tablets containing powdered fermented milk with L. helveticus in subjects with high-normal blood pressure or mild hypertension reduces elevated blood pressure without any adverse effects (R).

Long-term treatment with L. helveticus-fermented milk reduces arterial stiffness in hypertensive subjects (R).

L. plantarum reduced blood pressure in Russian adults with obesity (R).

L. faecium and S. thermophilus reduced systolic BP in overweight and obese subjects (R).

L. plantarum (R,R), L. johnsonii (R) and L. lactis (R,R) act as a blood pressure-lowering agent in rats.

22) Probiotics are Beneficial in Metabolic Syndrome

B. animalis ssp. lactis significantly reduced BMI, total cholesterol, low-density lipoprotein and inflammatory cytokines in patients with metabolic syndrome (R).

L. plantarum reduced total cholesterol, LDL-cholesterol, glucose and homocysteine levels in postmenopausal women with metabolic syndrome (R).

L. casei  improved insulin sensitivity in subjects with metabolic syndrome (R).

L. gasseri  decreased food and energy intake, and improved body weight, insulin resistance and cholesterol levels in rats with metabolic syndrome (MS) (R).

23) Probiotics Prevent Cardiovascular Disease

Probiotics and prebiotics have preventative and therapeutic effects on cardiovascular disease due to a reduction in total serum cholesterol, low-density lipoprotein (LDL-cholesterol), and inflammation (R).

Daily supplementation with S. boulardii  lowered remnant lipoprotein in hypercholesterolemic adults, a predictive biomarker and potential therapeutic target in the treatment and prevention of coronary artery disease (R).

L. casei  improves insulin sensitivity index in humans, an important risk factor for cardiovascular morbidity, especially stroke and coronary heart disease and mortality (R).

L. acidophilus consumption lead to 2.4% to 3.2% reduction in blood cholesterol in clinical studies. Since every 1% reduction in serum cholesterol concentration is associated with an estimated 2% to 3% reduction in risk for coronary heart disease, regular intake of L. acidophilus has the potential of reducing the risk for coronary heart disease by 6 to 10% (R).

L. acidophilus can protect against atherosclerosis through the inhibition of intestinal cholesterol absorption in mice fed a Western diet (R).

Lipoteichoic acid (LTA) from L. plantarum inhibits the production of proinflammatory cytokines and suppresses atherosclerotic plaque inflammation in mice (R).

L. acidophilus reduces cholesterol and inhibits the accumulation of lipoprotein in atherosclerotic plaques in mice (R).

L. acidophilus attenuates the development of atherosclerotic lesions in mice by reducing oxidative stress and inflammatory responses (R).

24) Probiotics Improve Our Gut Health

Probiotics can decrease the number of potentially pathogenic gastrointestinal microorganisms and pathogens, reduce gastrointestinal discomfort, flatulence and bloating, and improve bowel regularity (R).

B. animalis spp. lactis improved digestive comfort and GI symptoms in healthy adults (R,R).

Probiotic fermented milk containing B. animalis spp. lactis by healthy women may improve GI well- being and decrease the frequency of GI symptoms (R,R,R).

4 weeks’ supplementation with B. animalis ssp. lactis resulted in a clinically relevant benefit on defecation frequency in healthy adults with abdominal discomfort (R).

Ingestion of B. bifidum significantly decreased the prevalence of gastric and lower abdominal symptoms in adults taking no medication (R).

Administration of L. helveticus to healthy human subjects resulted in a significant increase in butyrate, beneficial for gut homeostasis (R).

Probiotics promote gastric mucus secretion (R). B. bifidum alleviates acute gastric injury by enhancing the production of gastric mucin in rats (R).

Probiotics Beneficially Modify Gut Microbiota

Probiotics in general tend to increase the levels of Lactobacilli and Bifidobacteria in the gut, while decreasing the levels of potentially pathogenic microorganisms (R,R,R,R,R,R,R,R,R,R,R,R,R).

Check individual probiotic posts for more information.

Probiotics Strengthen the Intestinal Barrier

The intestinal barrier separates the contents of the gut from the rest of the body. This barrier prevents the entry of harmful substances such as foreign antigens, toxins and microorganisms. Hyperpermeability of this barrier (“leaky gut”) contributes to the pathogenesis of several gastrointestinal disorders including IBD, Celiac disease and food allergy (R).

In humans, L. rhamnosus protects against disruption of the gastric mucosal barrier (R).

Fermented milk with L. paracasei  promotes intestinal epithelial cell growth and intestinal epithelial integrity and strengthens the intestinal barrier against chemical and inflammatory stimuli-induced damage (R).

L. paracasei  synbiotic therapy can prevent or repair colon damage in mice with acute colitis, where this bacterium completely restores epithelial barrier integrity (R,R).

In rats, B. bifidum or B. animalis protect the mucous membrane layer of the stomach (R).

S. cerevisiae strengthens epithelial barrier function (R). Oral treatment with viable or heat-killed S. cerevisiae strain prevents bacterial translocation, protects intestinal barrier integrity, and stimulates immunity in mice with intestinal obstruction (R).

Probiotics Prevent and Ameliorate Drug-Induced GI Damage

Probiotics maintain an individual’s intestinal microbiota in subjects receiving antibiotic treatment (R).

L. acidophilus administered with amoxicillin/clavulanate was associated with a significant decrease in patient complaints of GI side effects and yeast superinfection (R).

L. casei  is effective for the treatment of aspirin-associated small bowel injury in chronic low-dose aspirin users (R).

Long-term L. rhamnosus supplementation has an influence on the composition of the intestinal microbiota in children, and reduces the frequency of gastrointestinal complaints after antibiotic use, preventing certain bacterial infections for up to 3 years after the trial (R).

L. delbrueckii microcapsules relieve intestinal tissue damage in mice and ameliorate antibiotic-induced intestinal microbiota dysfunction (R).

L. paracasei therapy prevents antibiotic induced visceral hypersensitivity and restores normal gut permeability in rats (R).

L. fermentum  normalizes the composition of gut microbiota and alleviates ampicillin-induced inflammation in the colon in mice (R).

B. animalis ssp. lactis protects against NSAID-induced GI side effects in rats and may prevent more serious GI mucosal damage and/or enhance the recovery rate of the stomach mucosa (R).

S. boulardii  significantly reduced the numbers of gastric ulcers and the ulceration surface of the gastric mucosa in rats treated with ibuprofen (R).

S. thermophilus reduces inflammation and prevents chronic gastritis in aspirin-treated mice (R,R).

Probiotics Ameliorate Gastric Ulcers

Probiotics inhibit the development of acute gastric mucosal lesions and accelerate gastric ulcer healing (R).

Lactobacilli are particularly useful in promoting gastric ulcer healing in rats, when administered as an individual probiotic strain, such as L. rhamnosus, L. gasseri, or L. acidophilus or as a probiotic mixture (R,R,R,R,R,R).

B. breve and B. bifidum were able to repair and protect the mucosa of rats against gastric ulcers and erosions (R).

Pretreatment of mice with gastric ulcers with the probiotic C. butyricum alleviated the inflammation and gastric mucosal damage (R).

Certain yeasts, such as S. boulardii and S. cerevisiae have also shown beneficial effects in rats with gastric ulcers (R).

Probiotics Prevent and Treat Diarrhea

Use of probiotics in antibiotic-associated diarrhea decreased the risk of diarrhea by 52%, traveler’s diarrhea by 8%, and acute diarrhea from various causes by 34%. Probiotics were more effective in reducing the risk of acute diarrhea in children 57% versus 26% in adults (R).

Acute Infective Diarrhea:

L. casei reduces the incidence, duration, and severity of diarrhea in children (R,R).

L. paracasei effectively resolves acute diarrhea (R) and ameliorates non-rotavirus-induced diarrhea in children (R).

L. acidophilus reduced the duration of diarrhea in hospitalized, but not outpatient, children (R), and ameliorated both rotavirus-positive diarrhea (R), and nonrotavirus diarrhea in children (R).

L. acidophilus and B. bifidum shortened the duration of diarrhea in infants and children (R).

L. rhamnosus administration was associated with significantly lower rates of and symptomatic rotavirus gastroenteritis diarrhea in hospitalized children (R).

L. reuteri  decreases the incidence of diarrhea in children (R).

Formula supplemented with B. bifidum and S. thermophilus reduced the incidence of acute diarrhea and rotavirus shedding in infants admitted to hospital (R).

B. breve together with S. thermophilus reduces the severity of acute diarrhea and dehydration among healthy young infants (R).

B. animalis spp. lactis milk formula prevents diarrhea in infants, and decreases diarrhea frequency and duration (R,R,R).

S. boulardii  significantly reduces the frequency and duration of acute diarrhea in children (R,R,R,R,R,R,R,R). It also often reduces the length of ECU and hospital stay in acute infectious gastroenteritis in children (R,R).

S. boulardii  also decreases the duration and frequency of diarrhea, and ameliorates abdominal pain in adults (R), and shortens the hospital stay in patients with acute infectious diarrhea (R).

Antibiotic-Associated Diarrhea:

Treatment with L. rhamnosus reduced the risk of antibiotic-associated diarrhea (AAD) in patients treated with antibiotics from 22.4% to 12.3% (R).

L. casei intake was associated with a decreased risk of antibiotic-associated diarrhea (R,R).

L. helveticus and L. rhamnosus supplementation significantly reduced the duration of antibiotic-associated diarrhea in healthy adults receiving antibiotics (R).

B. animalis spp. lactis together with S. thermophilus reduced the frequency of antibiotic-associated diarrhea (AAD) in infants (R).

Concomitant administration of C. butyricum with antibiotics normalizes the intestinal microbiota, prevents the decrease of Bifidobacteria, and is effective for preventing and treating antibiotic-associated diarrhea in children (R).

Some studies report that S. boulardii  is not effective in preventing the development of antibiotic-associated diarrhea (R,R,R,R). However, many studies do, in fact, show that S. boulardii  is effective in reducing the risk of antibiotic-associated diarrhea in both children and adults (R,R,R,R,R,R,R).

B. subtilis significantly reduced the incidence of antibiotic-associated diarrhea and prevented nausea, bloating, vomiting and abdominal pain (R).

Traveler’s Diarrhea:

S. boulardii prevents traveler’s diarrhea, particularly in regions such as North Africa and in the Near-east (R).

Chemo- and Radiotherapy-induced Diarrhea:

Probiotics may have a beneficial effect in prevention of chemo- and radiotherapy-induced diarrhea, where they rarely cause adverse effects (R).

See individual probiotic posts for more information and animal studies.

Probiotics Relieve Constipation

L. paracasei relieves constipation (R).

Heat-killed L. brevis improved intestinal function in women with constipation (R,R).

L. reuteri helps constipation, increasing the number of bowel movements in adults (R) and infants (R).

B. breve is effective in diminishing abdominal pain and increasing stool frequency in children with functional constipation (R).

B. animalis spp. lactis showed beneficial effects on constipation in human studies (R,R,R).

B. coagulans improved constipation symptoms in children (R) and adults (R).

P. freudenreichii  relieves constipation in young healthy women (R).

Combined regimen of lactulose and live binary B. subtilis is an effective and safe therapeutic method for elderly with functional constipation (R).

See individual probiotic posts for more information and animal studies.

Probiotics Combat IBS

Irritable bowel syndrome is known to cause a reduction in intestinal Lactobacilli and Bifidobacteria (R). Probiotics improve global IBS symptoms, and decrease IBS-associated pain (R).

L. acidophilus reduced abdominal pain and discomfort in patients with irritable bowel syndrome (IBS) (R,R).

L. plantarum reduces gas problems and pain in people who suffer from irritable bowel syndrome (R).

Probiotics containing L. plantarum and B. breve in IBS decreased pain by 38% in the probiotic group compared with 18% in the placebo group, and after 28 days, pain was decreased 52% in the probiotic group compared with 11% in the placebo group (R).

L. rhamnosus can reduce pain frequency and intensity in children (R) and adults (R) with IBS.

L. rhamnosus has been proven to reduce symptoms in children with functional gastrointestinal disorders (R).

L. reuteri helps produce serotonin, and lessens susceptibility to gut problems and IBS (R).

L. rhamnosus, L. reuteri and VSL#3 significantly increased treatment success for functional gastrointestinal disorders (FGIDs) in children and adolescents (R).

A mixture of B. infantis, B. breve, and B. longum improve abdominal pain and the quality of life in children with irritable bowel syndrome (IBS) (R).

B. longum ssp. infantis reduces intestinal inflammation, improved abdominal pain/discomfort, bloating/distention, and bowel movement difficulty in patients with IBS (R,R,R).

B. bifidum significantly improved the pain/discomfort, distension/bloating, urgency and digestive disorder in patients with IBS (R).

Fermented milk containing B. bifidum improves symptoms in patients with functional gastrointestinal disorders (FGID). Abdominal pain, diarrhea, and constipation significantly improved, as did acid-related dyspepsia. Psychological symptoms such as anger and hostility also improved (R).

B. animalis has a beneficial effect on discomfort, bloating and constipation in constipation-predominant IBS patients (R).

B. animalis spp. lactis significantly improved objectively measured abdominal girth and gastrointestinal transit, as well as reduced symptomatology in IBS patients (R).

B. coagulans decreased bloating, vomiting, diarrhea, abdominal pain and stool frequency and increased the quality of life in patients with the diarrhea predominant irritable bowel syndrome (IBS) (R,R,R,R).

A combination of simethicone and B. coagulans reduced bloating and discomfort in patients with IBS (R).

L. brevis improves the quality of life, reduces diarrhea and abdominal pain and increases Bifidobacteria in patients with IBS (R).

S. boulardii  improved the cytokine profile, histology, and the quality of life in patients with diarrhea dominant irritable bowel syndrome (IBS-D) (R) or mixed-type IBS (R).

S. boulardii  alone or with mesalazine improved IBS-D symptoms (R). One study, however, found no improvement in IBS-D patients after S. boulardii treatment (R).

In one clinical trial, S. cerevisiae reduced abdominal pain and discomfort in subjects with IBS (R). In another trial, however, S. cerevisiae had no beneficial effect on IBS symptoms and wellbeing. However, it seemed to have some effect in the subgroup with constipation (R).

A combination product designated VSL#3, which contains large quantities of 8 bacterial species, was shown to significantly improve IBS symptoms (R).

Probiotics Ameliorate IBD

B. longum ameliorated ulcerative colitis symptoms in Japanese patients (R).

S. boulardii added to baseline therapy improved intestinal permeability in Crohn’s disease (CD) patients, even though complete normalization was not achieved (R). This probiotic also reduced the frequency of bowel movements in CD patients (R).

P. freudenreichii was effective in the treatment of mild to moderate ulcerative colitis in a human pilot study (R).

In Asian studies involving patients with ulcerative colitis, the addition of a B. subtilis probiotic significantly reduced the number of days with bloody stool, lead to complete remission without relapse, and significantly increased the efficacy of mesalazine or sulfasalazine therapy (R).

L. plantarum ameliorates ulcerative colitis in mice via both anti-inflammatory and immunomodulatory activities (R), and decreases the severity of intestinal inflammation in mice with inflammatory bowel disease (IBD) (R).

B. bifidum decreases symptoms of inflammatory bowel disease (IBD) in mice, such as thickened intestinal wall and inflammatory cell infiltration, and decreased inflammatory cytokine production (R).

Other probiotics that were effective in ameliorating colitis in animal models include L. casei  (R,R), L. paracasei  (R), L. salivarius (R), L. delbrueckii  ssp. bulgaricus (R), L. delbrueckii  ssp. lactis (R), L. helveticus (R), B. longum (R), B. animalis ssp. lactis (R,R,R), C. butyricum (R,R,R), B. coagulans (R,R), L. brevis (R,R,R), L. fermentum  (R,R,R,R), S. boulardii  (R), L. lactis (R,R,R,R), S. thermophilus (R), P. freudenreichii  (R,R,R), B. subtilisis (R,R,R,R) and S. cerevisiae (R,R).

B. longum ssp. infantis ameliorates colitis by decreasing Th1 and Th17 responses (R).

S. thermophilus also represses the Th17 response to ameliorate intestinal lesions (R).

S. boulardii  treatment limits the infiltration of Th1 cells into the inflamed colon and inhibits proinflammatory cytokine production in mice with IBD (R).

Note that L. crispatus can ameliorate colitis in mice (R), however, a specific strain, M206119, exacerbates intestinal inflammation (R).

Check individual probiotic posts for more information.

Probiotics Ameliorate Necrotizing Enterocolitis

Oral supplementation of L. paracasei  reduced the clinical progression of necrotizing enterocolitis in infants (R).

Prophylactic L. acidophilus and B. infantis reduced the incidence and mortality of necrotizing enterocolitis (NEC) in infants (R).

B. breve was associated with decreased risk of necrotizing enterocolitis in neonates (R).

Oral administration of B. breve reduces the production of butyric acid in infants, which may be helpful in protecting low birth weight infants from digestive diseases such as necrotizing enterocolitis (R).

However, one study found no benefit in B. breve administration for prevention of necrotising enterocolitis and late-onset sepsis in very preterm infants (R).

B. breve suppresses inflammation, reduces the pathology and increases survival in rats with necrotizing enterocolitis (R).

Probiotics Ameliorate Diverticular Disease

L. paracasei, in association with a high-fiber diet, is effective in reducing abdominal bloating and prolonged abdominal pain in patients with symptomatic uncomplicated diverticular disease (R).

25) Probiotics Boost Immunity

Gut microbiota cooperate with the host immune system through an extensive array of signaling pathways (R).

Studies with germ-free animals show that microbiota is necessary for the development and regulation of immunity in the gut, where it prevents the development of inappropriate inflammation (R).

Probiotics modify the immune system by stimulating anti-inflammatory cytokines, downregulating proinflammatory cytokines, and modulating white blood cell responses (R).

Probiotics activate both the innate and acquired immunity in humans (R,R,R,R,R,R,R,R,R,R,R).

L. paracasei, L. delbrueckii, L. fermentum, L. lactis, L. gasseri, B. longum, B. breve, B. animalis and other probiotics were shown to skew the Th1/Th2 balance toward Th1 (R,R,R,R,R,R,R,R,R,R) in infections and allergies.

Probiotics Combat Infections

L. paracasei prevents common infectious disease (CIDs) in children attending daycare (R).

L. helveticus supplementation significantly shortened the duration and decreased the number of symptoms of upper respiratory tract illness in athletes, and increased their sense of vigor (R).

Fermented milk containing L. johnsonii  suppressed infections in the elderly (R).

L. brevis reduces the incidence of influenza in elementary schoolchildren. The improvement is especially pronounced in unvaccinated individuals (R).

S. boulardii enhances the immune response in pediatric acute gastroenteritis (R).

Yogurt fermented with L. lactis lowers the risk of common cold in human subjects (R).

Fermented milk containing L. rhamnosus was efficient in reducing the risk on respiratory tract infections that lasted longer than three days in hospitalized children (R).

Preterm infants treated daily with L. rhamnosus in capsules starting within one week after birth, appear to have significantly lower incidence of respiratory tract infections (RTIs) and rhinovirus-induced episodes in the first 2 months (R).

Consumption of L. rhamnosus reduced the occurrence of respiratory illness in children attending day care centers (R).

Children receiving L. rhamnosus probiotics had fewer days with respiratory symptoms per month than the children in the control group (R).

Capsulated L. rhamnosus was shown to protect hospitalized patients against ventilator-associated pneumonia, mainly when caused by Gram-negative pathogens like Pseudomonas aeruginosa (R).

In cystic fibrosis patients with P. aeruginosa, long-term L. rhamnosus significantly decreased the incidence of pulmonary exacerbations and increased body weight (R).

L. casei  significantly lowered the incidence and duration of upper respiratory tract infections (URTIs) in healthy middle-aged office workers (R).

Similarly, in healthy shift workers, L. casei  decreased the incidence of gastrointestinal and respiratory common infectious disease (CIDs), increased the time to the first occurrence of CID, and reduced the total number of CIDs in the subgroup of smokers. In the course of CID, the total duration of fever was lower and an increase in leukocyte, neutrophil, and natural killer (NK) cell counts and activity was observed (R).

L. casei  also lowered the incidence of common infectious diseases (CIDs) in children (R), and decreased the duration of CID, and especially upper-respiratory-tract infections (URTI) such as rhinopharyngitis in the elderly (R).

In athletic men and women who engaged in endurance-based physical activities in winter, L. casei  lowered the proportion of subjects who experienced 1 or more weeks with upper-respiratory-tract infection (URTI) symptoms, and decreased the number of URTI episodes (R).

L. gasseri, B. longum and B. bifidum taken in winter by healthy subjects shortened common cold episodes by almost 2 days and reduced the severity of symptoms (R).

L. acidophilus, B. bifidum and B. animalis plus vitamin C reduced the incidence rate of upper respiratory tract infection, the number of days with symptoms and the absence from preschool in children (R).

A synbiotic containing L. acidophilus, B. infantis, and B. bifidum can provide effective control of respiratory infection and wheezing frequency in children under five years old (R).

The intake of yogurt fermented with L. delbrueckii  ssp. bulgaricus increases the activity of natural killer cells and reduces the risk of catching the common cold in elderly (R).

L. acidophilus suppressed all of the 74 gram-negative and 16 of gram-positive bacteria found in burn wounds, that can cause burn wound infections (R).

L. fermentum  reduced the duration and severity of respiratory illness in highly trained distance runners (R).

L. fermentum  reduced the severity of gastrointestinal and respiratory illness symptoms in male but not female cyclists (R).

L. fermentum  reduced gastrointestinal and upper respiratory tract infections in infants (R,R).

Oral administration of L. fermentum  potentates the immunologic response of an anti-influenza vaccine and may provide enhanced systemic protection by increasing the Th1 response and virus-neutralizing antibodies. The incidence of an influenza-like illness during 5 months after vaccination was decreased in the group that consumed this probiotic (R,R).

B. longum reduces the incidence of influenza and fever in subjects with influenza vaccination (R).

B. longum fed infants showed a trend toward fewer respiratory tract infections (R).

B. longum ssp. infantis triggers the anti-poliovirus response in infants (R).

B. breve significantly inhibited rotavirus multiplication and prevented rotavirus infection in infants (R).

B. animalis ssp. lactis reduces days with cold/flu in young healthy adults (R).

Infants and children receiving B. animalis ssp. lactis experienced fewer respiratory tract infections (R,R).

S. boulardii  reduces E. coli numbers in children (R).

S. boulardii  can treat B. hominis infection in children as efficiently as metronidazole (R).

S. boulardii  was effective in treating giardiasis when combined with metronidazole therapy in adult patients (R).

The addition of S. boulardii  to metronidazole in amebiasis significantly decreases the duration of (bloody) diarrhea and enhances clearance of cysts in children (R), and decreases the duration of symptoms and cyst passage in adults (R).

Prophylactic S. boulardii  supplementation is as effective as nystatin in reducing fungal colonization and invasive fungal infection, more effective in reducing the incidence of clinical sepsis and the number of sepsis attacks and has a favorable effect on feeding intolerance in very low birth weight infants(R).

B. subtilis decreased the frequency of respiratory infections in elderly subjects (R).

B. subtilis inhibits disease transmission in patients with acute non-typhoid Salmonella gastroenteritis (R).

Metabolites of B. subtilis decrease the resistance of urogenital pathogenic microflora to antibiotics in patients with urinary tract infections, resulting in accelerated elimination (R).

Probiotics were effective in treatment and prevention of urogenital infections in women as alternatives or co-treatments. They were effective for treatment and prevention of bacterial vaginosis, prevention of recurrences of candidiasis and urinary tract infections, and clearing human papillomavirus lesions. No study reported significant adverse events related to the probiotic intervention (R).

Probiotic supplementation with vaginal L. rhamnosus is useful in hindering bacteria growth especially after antibiotic therapy (R).

L. rhamnosus vaginal tablets have demonstrated to be a reliable topical effective and safe treatment to reduce the bacterial vaginosis recurrence rate (R).

Daily ingestion yogurt, enriched with L. acidophilus may reduce the episodes of bacterial vaginosis (R). Treatment of patients with bacterial vaginosis with L. acidophilus contributed to the restoration of a normal vaginal environment (R).

L. fermentum and L. plantarum significantly reduced bacterial vaginosis in women (R).

L. crispatus reduces recurrent urinary tract infections in premenopausal women (R).

L. crispatus inhibits Chlamydia trachomatis, the most common sexually transmitted bacterial pathogen, in human epithelial cells and macrophages (R,R).

Cervicovaginal mucus with high L. crispatus concentrations can trap the HIV virus (R).

B. coagulans reduced vaginosis symptoms in women when co-administered with antibiotics (R).

See individual probiotic posts for more information and animal studies

26) Probiotics can Alleviate Mucositis

Oral mucositis is one of the most common, debilitating complications of cancer treatments, particularly chemotherapy and radiation. L. brevis reduced the incidence and severity of anticancer therapy-induced oral mucositis and improved the tolerance to chemo-radiotherapy, and anticancer treatment completion (R).

L. acidophilus improved inflammatory and functional aspects of intestinal mucositis caused by chemotherapy in mice (R).

S. boulardii reduced the inflammation and dysfunction of the gastrointestinal tract in mice with intestinal mucositis (R).

In one study, S. thermophilus partially alleviated mucositis induced by administration of the antimetabolite chemotherapy drug methotrexate in rats (R), while in another study no protective effects were observed (R).

S. thermophilus partially prevented the loss of body weight induced by doxorubicin and slightly ameliorated doxorubicin-induced mucositis in rats (R).

S. thermophilus significantly reduced intestinal mucositis severity in rats treated with 5-Fluorouracil (R).

S. cerevisiae reduced oxidative stress, prevented weight loss and intestinal lesions, and maintained the integrity of the mucosal barrier in mice with mucositis (R).

27) Probiotics Help in Helicobacter pylori Treatment

Frequently used probiotic strains for H. pylori  infection are L. johnsonii, S. boulardii, L. acidophilus and B. animalis ssp. lactis (R).

Probiotics can inhibit H. pylori  infection by both non-immunological and immunological mechanisms (R).

L. delbrueckii  ssp. bulgaricus, and S. thermophilus improve H. pylori eradication rates in infected patients (R).

L. acidophilus decreases the viability of H. pylori and increases the eradication rate in infected patients (R).

Multi-strain probiotics, including L. acidophilus/B. animalis, significantly improve H. pylori  eradication rates, prevent adverse reactions and reduce antibiotic-associated diarrhea (R).

L. gasseri  suppressed H. pylori and reduced gastric mucosal inflammation in infected patients (R). A 4-week treatment with L. gasseri -containing yogurt improved the efficacy of triple therapy in patients with H. pylori infection (R). L. gasseri  yogurt also suppressed dyspeptic symptoms in H. pylori -infected patients (R).

Fermented milk containing L. johnsonii  co-administered with antibiotics was shown to have a favorable effect on H. pylori gastritis (R).

L. johnsonii  inhibits H. pylori colonization in children (R,R). and in asymptomatic volunteers (R).

A 2-week treatment with L. reuteri  significantly reduced H. pylori  overgrowth in otherwise healthy adults (R).

B. animalis spp. lactis and inulin significantly reduced treatment side effects and indirectly increased eradication rates by increasing patient compliance in patients with symptomatic H. pylori infection (R).

B. bifidum improved rates of upper gastrointestinal symptomatic subjects and total symptoms in patients with H. pylori infection (R).

The combined use of C. butyricum reduced the changes in the intestinal flora and decreased the incidence of gastrointestinal side effects in patients going through H. pylori  eradication therapy (R,R).

L. brevis treatment decreases H. pylori colonization in dyspeptic H. pylori patients and reduces polyamine biosynthesis (R).

B. subtilis containing probiotics improved H. pylori eradication and decreased diarrhea and total side effects, when used in conjuction with triple therapy (R).

S. boulardii  has a positive effect on reducing the colonization of H. pylori in the human gastrointestinal system but is not capable of its eradication when used as single therapy (R).

In patients with H. pylori  infection, there is evidence to recommend the use of S. boulardii  along with standard triple therapy as an option for increasing the eradication rates and decreasing overall therapy-related side effects, particularly diarrhea (R,R,R,R,R,R).

S. boulardii administered in addition to proton pump inhibitor-based triple therapy nonsignificantly lowered the incidence of nausea, vomiting, and abdominal pain and significantly lowered the incidence of stomatitis, constipation, and diarrhea in infected children (R).

S. boulardii improved anti-H. pylori therapy-associated diarrhea, epigastric discomfort, and treatment tolerability. In addition, S. boulardii  decreased post-treatment dyspepsia symptoms independent of H. pylori status (R).

L. paracasei supplementation prevents bowel symptom onset in patients on long-term proton pump inhibitors (R).

28) Probiotics Reduce Inflammation

Supplementation with a synbiotic, which is a mixture of L. casei, L. rhamnosus, S. thermophilus, B. breve, L. acidophilus, B. longum, L. delbrueckii ssp. bulgaricus and fructo-oligosaccharides, reduces inflammation markers in adults (R).

B. longum ssp. infantis reduced proinflammatory markers in patients with ulcerative colitis, chronic fatigue syndrome and psoriasis (R).

L. casei  improved natural killer (NK) cell activity and produced a more anti-inflammatory cytokine profile in healthy non-immunocompromised elderly subjects (R).

L. paracasei  significantly increases the release of pro-inflammatory cytokines and stimulates the innate immune system in human enterocytes and dendritic cells (DCs) (R).

L. delbrueckiissp. lactis was shown to possess anti-inflammatory effects (R). Skimmed milk with L. delbrueckiissp. bulgaricus inhibits the secretion of proinflammatory cytokines produced by accessory white blood cells (R).

L. acidophilus alleviates inflammation in human intestinal epithelial cells (R).

L. animalis ssp. lactis added to yogurt post-fermentation has anti-inflammatory properties in healthy adults (R).

L. animalis ssp. lactis inhibits inflammation in elderly volunteers (R).

B. longum ssp. infantis suppresses proinflamatory IL-17 cytokine production and may be useful in the treatment of Th17-mediated diseases (R).

L. reuteri  inhibits NF-κB, one of the most important factors in reducing whole-body inflammation (R).

See individual probiotic posts for animal studies and technical information.

29) Probiotics are Beneficial in Autoimmune Disorders

Probiotics and prebiotics have a potential to curb the autoimmune response and are being considered as an alternative to detrimental immunosuppressive drugs (R).

L. johnsonii  delayed or inhibited the onset of type 1 diabetes in diabetes-prone rats (R,R).

Intestinal dysbiosis, characterized by a reduced Firmicutes/Bacteroidetes ratio, has been reported in systemic lupus erythematosus (SLE) patients (R). B. bifidum supplementation prevents CD4+ lymphocyte over-activation, and may help in restoring the Treg/Th17/Th1 imbalance present in patients with SLE (R).

30) Probiotics can Ameliorate Celiac Disease

Try B. longum

B. longum ssp. infantis reduces gastrointestinal symptoms in untreated Celiac disease (CD) patients (R).

B. longum improved gut microbiota composition and immune parameters in children with newly diagnosed CD (R).

Oral administration of B. longum ameliorates gliadin (gluten)-mediated perturbations in liver iron deposition and mobilization in rats with CD (R).

B. longum attenuates the production of inflammatory cytokines and the CD4+ T-cell mediated immune response, and protects newborn rats against gliadin (gluten)-induced enteropathy (R).

B. breve decreases the production of the pro-inflammatory cytokine TNF in children with Celiac disease on a gluten-free diet (R).

Live B. animalis ssp. lactis bacteria can directly counteract the harmful effects exerted by celiac-toxic gluten (gliadin) to human intestinal cells (R).

L. casei  induced complete recovery in mice with enteropathy such as Coeliac disease (R).

31) Probiotics are Beneficial in Liver Disease

Probiotics found in yoghurt, L. delbrueckii ssp. bulgaris and S. thermophilus improve liver function (R).

Probiotics Ameliorate NAFLD

Some probiotics and synbiotics improve liver and metabolic parameters in patients with non-alcoholic fatty liver disease (NAFLD) (R).

In patients with NAFLD, L. acidophilus and B. lactis reduced serum levels of ALT, ASP, TC, and LDL-C (R).

In obese children with NAFLD, L. rhamnosus restored liver function (R).

Bifidobacteria, Lactobacilli, and S. thermophilus treatment for 4 months improved fatty liver severity and decreased BMI of children with NAFLD (R).

L. rhamnosus protects against NAFLD in mice, by increasing beneficial bacteria in the distal small intestine and attenuating liver fat accumulation and portal alanine-aminotransferase concentrations (R).

Treatment of L. plantarum for 5 weeks restored liver function in rats with non-alcoholic fatty liver disease (NAFLD) and decreased the levels of fat accumulation in the liver. In addition, the bacterium significantly reduced proinflammatory cytokines (R).

L. casei  protects against the onset of NAFLD in a mice (R), and suppresses nonalcoholic steatohepatitis development, by reducing blood lipopolysaccharide concentrations, suppressing inflammation and fibrosis in the liver, and reducing colon inflammation (R).

L. paracasei  symbiotic (containing arabinogalactan, fructooligosaccharides) lessens NAFLD progression in rats, lowers inflammatory markers and reduces the severity of liver injury and insulin resistance (R).

L. johnsonii  protects mice with NAFLD from liver steatosis and liver cell death (R).

C. butyricum increases cholesterol degrading enzymes and improves NAFLD in rats on a high-fat diet (R).

Probiotics are Beneficial in NASH

A synbiotic that contains five probiotics (L. plantarum, L. delbrueckii, L. acidophilus, L. rhamnosus, B. bifidum and inulin) over 6 months in adults with nonalcoholic steatohepatitis (NASH)  produced a significant decrease in intrahepatic triglyceride (IHTG) levels (R).

B. longum and fructo-oligosaccharides (FOS) significantly reduced AST, CRP, HOMA-IR, blood endotoxin and steatosis in patients with NASH (R).

L. paracasei  lowers liver fat deposition and serum ALT level in mice with NASH (R).

Probiotics Protect Against Alcohol-Induced Liver Injury

L. rhamnosus protects against alcoholic liver injury (R,R).

L. casei  attenuates alcohol-induced liver cell damage (R).

In chronic alcohol-induced mice, whey fermented with L. casei  significantly attenuates the increased levels of ALT, AST and triglyceride levels, increases antioxidant activity and improves liver parameters (R).

L. paracasei  reduces total blood and liver cholesterol in rats and decrease liver damage due to alcohol intake (R).

L. fermentum significantly alleviates liver damage in mice with alcoholic liver disease (R,R).

Oral administration of L. brevis ameliorates alcohol-induced liver injury and the fatty liver in mice. It significantly inhibited ALT and AST increase and decreased TG and total cholesterol in the liver (R).

Probiotics May Ameliorate Jaundice

Treatment of obstructive jaundice in rats with L. plantarum returned active liver barrier functions (R).

Probiotics Protect from Liver Injury

L. plantarum protects against oxidative stress and liver inflammatory injury in mice (R).

L. casei  significantly improved the survival of rats with liver injury, via its anti-oxidative and anti-inflammatory capacities (R).

Pretreatment with L. salivarius improves acute liver injury in rats (R).

L. salivarius exerts a good health-promoting effect in acute liver failure (R).

L. paracasei  restores gut microbiota and attenuates ischemia/reperfusion-related liver injury in rats (R).

S. boulardii  effectively prevents liver injury induced by Salmonella Enteritidis infection in mice (R).

Probiotics are Beneficial in Cirrhosis

B. faecium and B. subtilis shift the intestinal microbiota of patients with liver cirrhosis back towards levels observed in healthy subjects. These probiotics also reduce circulating endotoxin levels in cirrhotic patients with endotoxaemia (R).

B. longum and FOS improved biochemical parameters and neuropsychological tests in cirrhotic patients with minimal hepatic encephalopathy (MHE) (R).

S. boulardii promotes liver function and slows down the progress of liver fibrosis in rats (R).

32) Probiotics Combat Allergies

Probiotics harmonize Th1/Th2 imbalance in allergic conditions in adults (R).

Probiotics May Prevent Systemic Allergies

L. brevis suppresses systemic anaphylaxis (R) and inhibits IgE production and histamine secretion in allergic mice (R).

L. casei  protects mice from acute allergic inflammation (anaphylaxis) (R).

Probiotics May Prevent Allergies in Newborns

Consumption of L. rhamnosus-fermented milk by mothers and offspring showed a reduction in physical allergic symptoms in newborn mice (R).

Neonatal mother-to-offspring colonization with B. longum reduces allergic responses in mice (R).

Probiotics are Beneficial in Asthma

Human Studies:

L. salivarius decreases the secretion of proinflammatory cytokines and shows beneficial immunomodulatory activity in asthmatic subjects (R).

B. breve shows promising probiotic properties and beneficial immunomodulatory activity in allergic asthma (R).

C. butyricum improves asthma and serum specific IgE in the patients treated with specific immunotherapy (SIT), increases IL-10, and converts antigen-specific B cells to regulatory B cells (R).

Animal Studies:

Oral administration of L. rhamnosus attenuates the features of allergic asthma in mice (R,R).

L. salivarius decreases allergen-induced airway response in mice (R). It can alleviate the clinical symptoms, airway hyperreactivity and airway inflammation in mice with asthma (R).

L. gasseri  attenuates allergen-induced airway inflammation and IL-17 pro-inflammatory immune response in mice with allergic asthma (R).

L. lactis significantly attenuates atopic esophageal and bronchoalveolar eosinophilic inflammation in mice (R).

B. breve has strong anti-inflammatory properties in asthmatic mice (R,R,R).

L. paracasei  administration to mothers during gestation/lactation protects against airway inflammation in mice offspring (R).

B. longum attenuates allergic airway inflammation in mice (R).

B. bifidum significantly decreases airway hyperresponsiveness in allergic mice, decreases lung inflammation and lowers the Th2 response (R,R).

Probiotics Alleviate Allergic Rhinitis

17/22 trials showed significant benefit of probiotics clinically, whereas eight trials showed significant improvement in immunologic parameters in allergic rhinitis (R).

Citrus juice fermented by L. plantarum can improve the symptoms of Japanese cedar pollinosis (R).

C. butyricum can markedly enhance the efficacy of SIT on allergic rhinitis in patients with allergies (R).

Co-administration of C. butyricum markedly enhances the treatment of allergic rhinitis (R).

L. rhamnosus supplementation shows good clinical and immunologic response in children with allergic rhinitis (R).

Volunteers with seasonal allergic rhinitis treated with L. casei  showed a significant reduction in levels of antigen-induced cytokines (R).

A significant reduction of nasal symptoms and improved quality of life were achieved in patients with Japanese cedar pollinosis, who received L. paracasei  when pollen scattering was low. However, the effects were limited during the peak period (R).

At least five clinical studies with L. paracasei  demonstrated clinically significant improvements in allergic rhinitis (R), while one did not (R).

Subjects with a medical history of allergic rhinitis to grass pollen that received L. paracasei -fermented milk had lower nasal congestion and nasal itching (R).

In children with perennial allergic rhinitis, L. paracasei  improved symptoms of sneezing, itchy nose, and swollen eyes (R).

L. paracasei  improved the quality of life of subjects with persistent allergic rhinitis who were being treated with an oral H1-antihistamine. In this study, nasal symptoms had not changed, but ocular symptoms had consistently improved (R).

Heat-killed L. paracasei  can effectively improve the overall quality of life in patients with allergic rhinitis induced by house dust mite in human subjects (R).

L. acidophilus alleviats allergic symptoms in patients with Japanese cedar pollinosis (R,R).

L. acidophilus alleviates the symptoms in patients with perennial allergic rhinitis (R).

Heat-killed L. gasseri  improved nasal symptoms and pollen-specific IgE levels in subjects with Japanese cedar pollinosis (R).

The addition of L. johnsonii  to levocetirizine improved perennial allergic rhinitis in children (R).

Intake of yogurt or powder supplemented with B. longum alleviated subjective symptoms and affected blood markers of allergy in individuals with Japanese cedar pollinosis (R,R,R). Nasal symptoms such as itching, rhinorrhea, and blockage, as well as throat symptoms tended to be relieved with this probiotic (R).

B. animalis ssp. lactis improved nasal symptoms in subjects suffering from seasonal allergic rhinitis (R).

Check individual posts for more information and animal studies.

Probiotics Combat Food Allergies

L. rhamnosus accelerates oral tolerance acquisition in cow’s milk allergic infants (R,R).

L. rhamnosus decreased the allergic response to peanuts in children (R).

In milk-hypersensitive adults, L. rhamnosus has been shown to reduce the immunoinflammatory response (R).

L. plantarum reduces the allergenicity of soy flour (R).

L. salivarius, L. paracasei, B. animalis and B. bifidum prevent atopic sensitization to common food allergens and thereby reduce the incidence of atopic eczema in early childhood (R).

L. delbrueckii  ssp. bulgaricus degrades the allergenic whey protein β-lactoglobulin and inhibits IgE binding in allergic patients (R).

L. helveticus alone or in combination with S. thermophiles effectively reduces the antigenicity of α-lactalbumin and β-lactoglobulin, the major allergens in cow’s milk (R).

L. helveticus can significantly degrade the major allergens in propolis, including esters of caffeic acid (R).

L. fermentum  degrades αS1-casein and lowers the recognition and the binding of this casein to IgE from the blood of patients with cow’s milk allergy (R).

B. breve improves symptoms of allergic hypersensitivity to cow’s milk in infants (R).

Probiotics Alleviate Eczema

The combination of prenatal maternal (2-4 weeks) and postnatal pediatric (6 months) L. rhamnosus treatment in families with a history of atopic disease, significantly lowers the risk of eczema at the age of 2, 4 and 7 (R).

In infants receiving either L. rhamnosus or B. lactis after 2 months, eczema symptoms were significantly improved (R).

L. rhamnosus efficiently prevents the development of eczema and possibly also atopic sensitization in high-risk infants up to 6 years old (R).

Cumulative prevalence of eczema and prevalence of rhinoconjunctivitis were significantly reduced in the children taking L. rhamnosus (R).

B. animalis ssp. lactis significantly improved eczema symptoms in infants (R).

When administered to pregnant women with a family history of allergic diseases, a mixture of B. bifidum, B. lactis, and L. acidophilus significantly lowered the prevalence and incidence of eczema in infants at high risk of allergy (R).

B.breve reduced the risk of developing eczema and atopic sensitisation in infants at high risk of allergic disease (R).

B. bifidum has a positive effect on the prevention and treatment of eczema in infants (R).

The use of multi-strain probiotics appeared to be most effective for eczema prevention (R).

Probiotics Prevent Atopic Dermatitis

Use of L. rhamnosus by mothers lowers the risk of developing atopic dermatitis during the first 2 years of life (R).

L. rhamnosus is effective in decreasing symptoms of atopic dermatitis after an 8-week treatment in children aged 4-48 months (R).

Daily intake of citrus juice containing heat-killed L. plantarum alleviates symptoms of atopic dermatitis in humans (R).

L. salivarius improves symptoms in children (R,R), and adults with atopic dermatitis (R).

Heat-killed L. paracasei  improved atopic dermatitis (AD) in adult patients (R).

Long-term oral administration of L. acidophilus significantly restored Th1/Th2 balance and ameliorated the symptoms of atopic dermatitis in children (R).

Prolonged ingestion of L. acidophilus significantly decreased eczema area and severity index in patients with adult atopic dermatitis (R,R). The probiotic also suppressed scratching behavior (R).

B. breve improves symptoms of atopic dermatitis in infants (R,R).

Topical administration of an S. thermophilus-containing cream to patients with atopic dermatitis increased ceramide levels and improved the signs and symptoms of atopic dermatitis (i.e. erythema, scaling, pruritus) (R).

See individual probiotic posts for more information and animal studies.

33) Probiotics Alleviate Lactose Intolerance

L. delbrueckii ssp. bulgaricus and S. thermophilus improve lactose digestion in the gastrointestinal tract and reduces symptoms of lactose intolerance (R).

L. acidophilus may improve lactose digestion and tolerance (R,R).

34) Probiotics May be Beneficial in Histamine Intolerance

L. plantarum is able to degrade biogenic amines (R) and can potentially help with histamine intolerance.

L. casei  degrades biogenic amines (BAs) and reduces histamine and tyramine accumulation in cheese (R).

Note that some probiotics can produce/increase biogenic amines (see Safety section).

35) Probiotics can Decrease Oxalate

L. gasseri  degrades oxalate in laboratory experiments and may be beneficial in managing oxalate kidney stone disease (R).

A mixture of L. casei  and B. breve possess a variable lowering effect upon urinary oxalate excretion that may be dependent on dietary oxalate intake (R).

B. animalis ssp. lactis possesses the oxc gene, encoding oxalyl-coenzyme A (CoA) decarboxylase, a key enzyme in oxalate degradation (R). B. animalis ssp. lactis significantly decreased urinary oxalate excretion in mice with hyperoxaluria by degrading dietary oxalate thus limiting its absorption across the intestine (R).

36) Probiotics are Beneficial for the Skin

Probiotics can restore acidic skin pH, alleviate oxidative stress, attenuate photoaging, improve skin barrier function, and enhance hair quality (R).

Topical application of probiotic bacteria has a direct effect at the site of application by enhancing the skin natural defense barriers. Additionally, probiotics as well as resident bacteria can produce antimicrobial peptides that benefit skin immune responses and eliminate pathogens (R).

Try: L. plantarum, B. breve

Human Studies:

L. plantarum improves skin hydration has anti-photoaging effects on human skin (R,R). L. plantarum further increases hydration and may help to improve skin barrier function (R).

L. plantarum inhibits degradation of collagen, promotes collagen synthesis, and decreases reactive oxygen species (ROS) production (R).

In clinical trials, L. plantarum significantly increased the skin water content in the face and hands. Volunteers in the probiotic group had a significant reduction in wrinkle depth at week 12, and skin gloss was also significantly improved by week 12. Skin elasticity in the probiotic group improved by 13.17% after 4 weeks and by 21.73% after 12 weeks (R).

L. paracasei  contributes to the reinforcement of skin barrier function, inhibits water loss, decreases skin sensitivity and modulates the skin immune system leading to the preservation of skin homeostasis (R).

L. paracasei  decreases skin sensitivity and increases barrier function recovery (water retention) in women (R).

L. johnsonii  significantly inhibited the development of UVA-induced skin lesions in clinical studies (R).

Supplementation with L. rhamnosus normalizes skin expression of genes involved in insulin signaling and improves the appearance of adult acne (R).

B. longum extract, when applied to the skin, was able to improve inflammation parameters, decrease skin sensitivity, increase skin resistance against physical and chemical aggression, and decrease skin dryness in volunteers with sensitive skin (R).

B. breve and galactooligosaccharides (GOS) increased skin hydration and clearness in healthy young and adult women (R,R).

L. lactis increased sebum content, thereby potentially reinforcing the skin barrier in healthy young women (R). L. lactis maintained skin hydration, and improved subjective skin elasticity in middle-aged Japanese women (R).

Ceramides play an essential role in the barrier and water-holding functions of the healthy skin. A significant increase in skin ceramide levels was observed in healthy subjects after treatment with a cream containing a preparation of S. thermophilus (R).

Topical treatment with an S. thermophilus-containing cream increased ceramide levels and increased hydration in the skin of healthy elderly women (R).

S. cerevisiae extract (SCE) is used in cosmetics, where it reduces oxidative stress and improves skin conditions. It was shown to enhance skin moisture and skin microrelief in volunteers (R).

Animal Studies:

In hairless mice, L. plantarum decreased UVB-induced epidermal thickness, suppressed water loss and increased the ceramide level (R,R).

B. longum exerts photoprotective effects on the skin in mice (R).

B. bifidum decreases the amount of intracellular melanin and exhibits antioxidant properties in mice, and may be beneficial as a skin-whitening ingredient in various skin hyperpigmentation disorders (R).

B. breve prevents water loss, improves skin elasticity and hydration, and attenuates the damage induced by chronic UV irradiation (photoaging) in mice (R,R,R).

L. brevis increases blood flow and decreases transepidermal water loss in rats, and could be a useful substance in the treatment/prevention of skin problems, specifically chapped or dry skin (R).

Animal research on L. reuteri has shown potential for improving skin quality (thickness and “glow”) and creating thick, lustrous hair (R).

37) Probiotics are Beneficial in Patients Receiving Hemodialysis

Oral administration of B. longum decreases serum phosphate levels in patients receiving haemodialysis (HD) (R).

The administration of B. longum can also decrease the concentrations of indoxyl sulfate and P-cresol in HD patients (R,R).

In addition, Bifidobacteria produce vitamin B12 and folate, which can normalize serum homocysteine levels in HD patients (R).

38) Probiotics Enhance Wound Healing

L. plantarum reduced the bacterial load of infected chronic venous ulcer wound, reduces neutrophils, apoptotic and necrotic cells, and induced wound healing in both diabetics and non-diabetics (R).

Topical treatment with a water-insoluble glucan from S. cerevisiae enhanced venous ulcer healing in humans. In a patient who had an ulcer that would not heal for over 15 years, this treatment caused a 67.8% decrease in the area of the ulcer (R).

Supplementing the rat microbiome with L. reuteri in drinking water cuts wound-healing time in half compared to control animals (R).

39) Probiotics Combat Toxins and Pollutants

Look for: L. plantarum, L. rhamnosus, L. casei

Dietary exposure to heavy metals may have detrimental effects on human and animal health, even at low concentrations. L. rhamnosus, P. freudenreichii and their combination were found to bind cadmium and lead efficiently at low concentration ranges commonly observed in foods (R).

Furthermore, dietary supplementation with L. rhamnosus reduced the absorption and toxicity of consumed organophosphate pesticides in Drosophila (R).

L. plantarum alleviates cadmium (Cd) – induced cytotoxicity in the human intestinal cells and mice in the laboratory (R,R).

L. plantarum protects against aluminum toxicity in mice, by reducing intestinal aluminum absorption and tissue accumulation, and ameliorating liver damage, kidney, and brain oxidative stress (R).

Treatment with L. plantarum alleviates copper toxicity, by increasing copper excretion and reducing the accumulation of copper in tissues. L. plantarum also reversed oxidative stress induced by copper exposure, recovered the ALT and AST blood levels and improved the spatial memory of mice (R).

L. casei  and L. helveticus can bind to and inactivate heterocyclic aromatic amines (HACs), the most abundant mutagens in fried red meat, decreasing their concentration and their toxicity (R,R).

L. casei  decreases the cytotoxic effects of pesticides on human cells (R).

L. casei  supplementation reduces the level of aflatoxin in blood, and can improve the adverse effect on body weight and blood parameters in rats (R,R). A fermented milk drink containing L. casei may reduce aflatoxin toxicity in humans (R).

L. paracasei  reduced the adverse effects of Zearalenone (ZEN), an estrogenic toxin produced by Fusarium fungi species in pre- or post-harvest cereals in mice (R).

Organophosphorus hydrolase (OpdB) of L. brevis is able to degrade organophosphorus pesticides (R).

S. cerevisiae possesses the ability to bind and degrade mycotoxins (R). S. cerevisiae improved weight gain and reduced genotoxicity of aflatoxin in mice fed with contaminated corn (R).

40) Probiotics Reduce MSG

Capsules containing L. brevis reduce monosodium glutamate (MGS) levels and MSG symptom complex in humans (R).

L. brevis inhibits the absorption of MSG from the intestine into the blood in mice (R).

41) Probiotics May Increase Testosterone Levels

L. reuteri  sustains youthful serum testosterone levels and testicular size in aging mice (R,R).

A probiotic containing L. acidophilus, B. bifidum and L. helveticus elevates testosterone levels in rabbits (R).

42) Probiotics May increase Oxytocin

L. reuteri  increases the levels of the “feel good” hormone oxytocin (R).

43) Probiotics Combat Fatigue

Look for: L. acidophilus and L. gasseri

L. acidophilus reverses immune dysfunction in fatigued athletes (R).

L. acidophilus decreases chronic fatigue following exercise and attenuates stress in rats (R).

L. gasseri  prevents the reduction in natural killer (NK) cell activity due to strenuous exercise and elevates mood from a depressed state in university-student athletes (R).

L. gasseri  and αLA alleviate minor resting fatigue in university-student athletes after strenuous exercise (R).

44) Probiotics Enhance Muscle Recovery and Boost Athletic Performance

B. coagulans enhances protein absorption, and thereby indirectly improves recovery and training adaptations (R).

B. coagulans in combination with protein reduced muscle damage and soreness, improved recovery and maintained physical performance in athletes after strenuous exercise (R).

Increase in vertical jump power was noted following 8 weeks of full body workouts 4-times per week daily while ingesting B. coagulans (R).

Four weeks of supplementation with a multi-strain probiotic increased running time to fatigue in the heat in male runners (R).

L. plantarum significantly decreased body weight and increased relative muscle weight, grip strength and endurance swimming time in mice (R).

45) Probiotics Ameliorate Arthritis

Human Studies:

L. casei  supplementation helps alleviate symptoms and improve inflammatory cytokines in women with rheumatoid arthritis (R).

A mix of L. acidophilus, L. casei  and B. bifidum improved rheumatoid arthritis, decreased insulin levels, and improved total- and low-density lipoprotein-cholesterol levels (R).

Adjunctive treatment with B. coagulans was safe and effective for patients suffering from rheumatoid arthritis. B. coagulans improved pain, improved self-assessed disability, reduced CRP levels, and improved the ability to walk 2 miles, reach, and participate in daily activities (R).

Animal Studies:

L.casei  protects mice from autoimmune arthritis (R), and consumption of L. casei  prior to infection abolishes intestinal and joint inflammation triggered by Salmonella in mice (R).

L. casei  positively contributes to osteoarthritis treatment in rats, by reducing pain, inflammatory responses, and articular cartilage degradation. L. casei  together with glucosamine decreased expression of various pro-inflammatory cytokines and matrix metalloproteinases, while up-regulating anti-inflammatory cytokines (R).

Similarly, L. casei  effectively suppressed symptoms of rheumatoid arthritis in rats: paw swelling, lymphocyte infiltration and destruction of cartilage tissues. Anti-inflammatory cytokines were increased, while pro-inflammatory cytokines were decreased (R,R,R).

Oral intake of skimmed milk fermented with L. delbrueckii  ssp. bulgaricus markedly inhibits the development of arthritis in mice (R).

L. acidophilus decreases arthritis symptoms and maintains normal histology of reproductive organs in rats (R).

L. acidophilus showed effects comparable to the drug indomethacin, in decreasing organ damage associated with arthritis in rats. This probiotic down-regulated pro-inflammatory and up-regulated anti-inflammatory cytokines (R).

L. helveticus strongly alleviated symptoms of arthritis in mice (R).

B. coagulans significantly inhibits fibrinogen (Fn), blood amyloid A and pro-inflammatory cytokine production in arthritic rats (R).

46) Probiotics are Beneficial for Dental Health

Probiotics are beneficial for managing gingivitis or periodontitis (R).

L. rhamnosus reduces oral counts of Streptococcus mutans, a bacterium correlated with caries formation (R).

L. casei  has a bactericidal effect on all analyzed species isolated from dental plaque, while the mix culture of L. acidophilus and B. animalis has only a bacteriostatic effect (R).

S. thermophilus inhibits the growth of P. gingivalis, and reduced the emission of volatile sulfur compounds that can cause oral malodor (R).

A bacteriocin produced by L. paracasei  inhibits P. gingivalis associated with periodontal disease (R).

Human Studies:

Long-term consumption of L. rhamnosus containing milk reduces caries development in children (R).

Heat-killed L. plantarum can decrease the depth of periodontal pockets in patients undergoing supportive periodontal therapy (R).

Oral administration of L. casei  reduced the number of pathogenic (periodontopathic) bacteria in healthy volunteers with mild to moderate gum inflammation (periodontitis) (R).

L. salivarius beneficially changed the bacterial population of gum plaque in volunteers (R).

L. salivarius increases resistance to caries risk factors in volunteers (R).

Oral administration of L. salivarius improved bad breath, showed beneficial effects on bleeding on probing from the periodontal pocket, and inhibited the reproduction of “bad” bacteria (R,R,R,R).

Oral L. paracasei  significantly reduced salivary S. mutans (R,R,R), and increased Lactobacilli in adults (R).

L. brevis improves pH, significantly reduces salivary mutans streptococci and bleeding on probing in high caries risk schoolchildren (R).

L. brevis has anti-inflammatory effects and can bring about the total disappearance or amelioration of clinical symptoms in patients with periodontitis (R).

L. brevis exerts anti-inflammatory properties by preventing nitric oxide synthesis and may delay gingivitis development in humans (R).

B. subtilis reduces periodontal pathogens in humans (R).

Oral L. reuteri  containing tablets significantly reduced inflammation in patients with chronic periodontitis (R).

Animal Studies:

L. brevis inhibits periodontal inflammation, significantly decreases bone loss and lowers the count of anaerobic bacteria in mice with periodontitis (R).

B. subtilis and Bacillus licheniformis supplementation provided a protective effect against bone loss in rats with periodontitis (R).

S. cerevisiae, as monotherapy or as an adjuvant, accelerated the tissue-repair process and ameliorated periodontitis in rats (R).

47) Probiotics can Improve Lung Injury and Inflammation

B. longum treatment significantly improved lung injury following infection and sepsis in mice. This probiotic also decreased lung inflammatory responses (R).

48) Probiotics are Beneficial in Smokers

Cigarette smoking reduces natural killer cell (NK cell) activity. L. casei  intake prevented the smoke-dependent NK activity reduction in Italian male smokers (R).

In healthy shift workers, L. casei  reduced the total number of clinical infectious diseases (CIDs) in the subgroup of smokers (R).

B. breve suppresses inflammatory agents in macrophages and may be useful in cigarette smoke-associated disease such as Chronic obstructive pulmonary disease (COPD) (R).

L. salivarius improved periodontal clinical parameters in smokers (R).

49) Probiotics are Good for the Bones

Bone is an organ that the gut has long been known to regulate through absorption of calcium, the key bone mineral (R).

Administration of probiotics leads to higher bone mineralization and greater bone strength in animals. The preferential bacterial genus that has shown these beneficial effects in bone is Lactobacillus (R).

L. helveticus increased serum calcium level in geriatric volunteers (R).

L. helveticus fermented milk whey contains bioactive components that increase bone formation (R).

L. helveticus-fermented milk prevented bone loss by decreasing bone turnover and increasing the bone mineral density in rats (R,R).

B. longum supplementation alleviated bone loss, and increased bone formation parameters and bone mass density in ovariectomized rats (R).

50) Probiotics Boost Female Fertility

L. plantarum ameliorated inflammation induced infertility in mice (R).

L. plantarum reinforced natural microflora and lead to a resurge of fertility in mice infected with E. coli (R).

51) Probiotics are Beneficial in Endometriosis

L. gasseri  improves menstrual pain and dysmenorrhea in patients with endometriosis (R).

L. gasseri  inhibits the growth of endometrial tissue in the abdominal cavity in mice and rats (R).

52) Probiotics are Beneficial in Pregnancy

Use of a specific set of probiotics during the first 1,500 days of life can lower the risk of infections and inflammatory events in infants (R).

L. rhamnosus affects the immune regulation and immune responses favorably in mothers and offspring. In addition, some of the beneficial effects of prenatal L. rhamnosus supplementation extend into postnatal life of the offspring, suggesting a possible immunoprogramming effect of L. rhamnosus (R).

Prenatal supplementation with L. rhamnosus has been reported to change the composition of the newborn microbiota, promoting a beneficial profile dominated by Bifidobacteria (R).

The intake of milk fermented with L. casei  during the lactation period modestly contributes to the modulation of the mother’s immunological response after delivery, and decreases the incidence of gastrointestinal episodes in the breastfed child (R).

B. animalis spp. lactis supplementation in pregnancy has the potential to influence fetal immune parameters as well as immunomodulatory factors in breast milk (R).

B. animalis ssp. lactis mitigates the negative immune-related effects of not breastfeeding and cesarean delivery by augmenting the immune response, evidenced by increased anti-rotavirus- and anti-poliovirus-specific IgA (R).

Oral administration of L. salivarius during late pregnancy appears to be an efficient method to prevent breast infection in pregnant women (R).

L. acidophilus, L. casei and B. bifidum significantly decreased fasting plasma glucose, insulin levels, and insulin resistance and increased insulin sensitivity in pregnant women with gestational diabetes mellitus. In addition, significant decreases in serum triglycerides and VLDL cholesterol concentrations were recorded (R).

B. coagulans containing symbiotic decreased blood insulin levels, HOMA-IR and HOMA-B in pregnant women (R).

Preeclampsia is associated with impaired antioxidant defense that results in maternofetal complications. S. cerevisiae scavenged nitric oxide radicals and decreased oxidative stress in red blood cells and alleviated stress status in the preeclamptic fetus (R).

Continuous consumption of fermented milk containing L. casei  alleviates constipation-related symptoms, provides satisfactory bowel habit and results in earlier recovery from hemorrhoids in women after childbirth (R).

L. fermentum  alleviates pain and reduces the load of Staphylococcus in the breastmilk of women suffering from painful breastfeeding (R).

53) Probiotics have a Positive Effect on Infant Growth

B. animalis spp. lactis supplementation had a positive effect on growth in vulnerable infants, such as infants born to mothers with HIV (R), and preterm infants (R).

B. breve significantly decreased aspirated air volume and improved weight gain in very low birth weight infants (R).

L. plantarum strain maintained the growth of infant mice during chronic undernutrition (R).

54) Probiotics Improve Feeding Tolerance

Preterm infants supplemented with B. coagulans had improved feeding tolerance (R).

Prophylactic supplementation of S. boulardii  improved weight gain, improved feeding tolerance, and had no adverse effects in preterm infants >30 weeks old (R).

Orally administered S. boulardii  reduced feeding intolerance and clinical sepsis in very-low-birth-weight (VLBW) infants (R).

55) Probiotics are Beneficial in Aging

Human Studies:

Levels of Bifidobacteria decrease as we age (R).

B. animalis spp. lactis beneficially modifies gut microbiota in elderly, by increasing Bifidobacteria, Lactobacilli, and Enterococci and reducing Enterobacteria (R).

B. animalis spp. lactis can enhance natural immunity in healthy elderly subjects (R). B. animalis spp. lactis increases leukocyte phagocytic and NK cell tumor-cell-killing activity in the elderly and increases the proportions of total, helper (CD4(+)), and activated (CD25(+)) T lymphocytes and natural killer cells (R,R,R).

B. longum stimulates the immune functions in the elderly (R).

B. bifidum and L. acidophilus positively modulate of the immunological and inflammatory response in elderly subjects (R).

L. delbrueckii ssp. bulgaricus could favor the maintenance of an adequate immune response in the elderly, mainly by slowing the aging of the T-cell subpopulations and increasing the number of immature T cells which are potential responders to new antigens (R).

L. acidophilus increases Bifidobacteria levels and beneficially changes microbiota in elderly subjects (R).

Heat-killed L. gasseri  enhances immunity in the elderly. This probiotic increases the number of CD8(+) T cells and reduces CD28 expression loss in CD8(+) T cells (R).

Animal Studies:

Feeding of probiotic bacteria (L. reuteri) to aged mice induced integumentary changes mimicking peak health and reproductive fitness characteristic of much younger animals (R).

Probiotic Dahi with L. lactis, L. acidophilus and B. bifidum reversed age related decline in expression of biomarkers of ageing, PPAR-α, SMP-30 and klotho in hepatic and kidney tissues in mice (R).

L. lactis along with L. acidophilus or combined with L. acidophilus and B. bifidum reversed age related decline in immune functions and improve lymphocyte functions in ageing mice (R).

Heat-killed L. gasseri  increases natural killer cell (NK cell) activities and enhances cell-mediated immunity in aged host animals, thereby altering age-related immunosenescence (R).

Dahi containing L. acidophilus was effective in reversing age-related immune function decline in mice (R), where this probiotic also combats oxidative stress and molecular alterations associated with aging (R).

L. fermentum  alleviates immunosenescence by enhancing antioxidant enzyme activities, and was shown to reduce E. coli infection in aging mice (R).

L. johnsonii  helps recover nutritional status and systemic immune responses in aged mice (R).

Long-term oral intake of L. lactis suppressed the reduction of bone density and body weight in senescence-accelerated mice (R).

B. bifidum delays immunosenescence in mice by enhancing the anti-oxidation activity in thymus and spleen, and by improving the immune function (R).

Intake of heat-killed L. lactis altered the intestinal flora, affected plasma metabolite levels, including fatty acid levels, and slowed down age-related hearing loss in mice, by inhibiting the loss of neurons and hair cells in mouse inner ear (R).

In mice, L. reuteri  increased thyroid size and activity (increasing T4 levels), lessening the fatigue and weight gain associated with aging and causing a more youthful physical appearance (R).

56) Probiotics can Alleviate Pain

Oral administration of L. acidophilus induces the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells and mediates analgesic functions in the gut similar to the effects of morphine (R).

B. coagulans + fructooligosaccharide (FOS) decreased abdominal pain duration and frequency in children with GI disorders (R).

B. coagulans synbiotic seems to be effective in the treatment of childhood functional abdominal pain (R).

B. coagulans significantly improved abdominal pain and the quality of life in adults with postprandial intestinal gas-related symptoms and no GI diagnoses (R).

In animal models of gut pain, L. reuteri  has been shown to lower the activation of the nervous system and lessen pain (R,R).

L. reuteri  ingestion impacts the nerves in such a way that it may slow gut motility (improving cases of diarrhea) and decrease pain perception (R).

L. rhamnosus can attenuate neonatally induced chronic visceral pain, and significantly alters levels of serotonin, noradrenaline, and dopamine in rats (R).

57) Probiotics can be Beneficial After Surgery

A symbiotic containing L. acidophilus, L. rhamnosus, L. casei, B. bifidum and fructooligosaccharides reduced postoperative mortality, lowered the incidence of postoperative infections, shortened the duration of antibiotic therapy, and decreased noninfectious complications, decreasing overall hospital stay in patients undergoing surgery for periampullary neoplasms (R).

Orally administered B. breve improved the intestinal environment, and suppressed bacterial translocation in pediatric surgical cases (R,R).

58) Probiotics Combat Candida

Clinical trials have shown the beneficial effects of probiotics in reducing oral, vaginal, and enteric colonization by Candida. Probiotics alleviate clinical signs and symptoms, and, in some cases, reduce the incidence of invasive fungal infection in critically ill patients (R).

In patients with vulvovaginal candidiasis, L. plantarum reduces vaginal discomfort after conventional treatment, improves vaginal bacteria content and the vaginal pH value (R).

In a clinical trial L. plantarum use was associated with a three-fold reduced risk of recurrence of vulvovaginal candidiasis (R).

L. fermentum and L. acidophilus maintain the vaginal biofilm and hinder the persistence of vulvovaginal infection caused by Candida in women (R).

L. reuteri  alone or with L. rhamnosus can inhibit the growth of Candida in the vagina (R,R).

L. rhamnosus has been shown to prevent enteric colonization by Candida species in preterm neonates (R).

Oral L. reuteri  supplementation was effective as nystatin in suppressing candidiasis in preterm infants and more effective at reducing the incidence of sepsis (R,R).

L. reuteri  lozenges were shown to fight oral candida in a study of older patients (R).

S. cerevisiae, when administered orally, colonizes the bowel of healthy volunteers and can potentially replace resident Candida species (R).

Vaginal administration of S. cerevisiae positively influences the course of vaginal candidiasis by accelerating the clearance of Candida (R).

See individual probiotic posts for more information and animal studies.

59) Probiotics May Protect from Heat Stress

Exposure to extreme heat can cause illnesses and injuries. B. subtilis was effective in the prevention of complications related to heat stress in rats. When rats were subjected to heat stress (45°C), adverse effects such as morphological changes in the intestine, bacterial translocation, elevated levels of LPS and IL-10, and increased vesiculation of erythrocytes were observed only in animals not protected with B. subtilis (R).

60) Probiotics May be Beneficial In HIV Infected Patients

Treatment with S. boulardii  decreases microbial translocation (LBP) and inflammation parameters in HIV-1-infected patients with long-term virologic suppression (R).

61) Probiotics Combat and Prevent Cancer

Probiotic bacteria have shown anti-tumor activities, and can reduce the risk of cancer. They are effective in delaying cancer onset and progression as well as in controlling cell growth mechanisms (R).

Studies in Humans:

Consumption of soy isoflavones in combination with L. casei  decreased the risk of breast cancer among Japanese women (R).

L. casei  administration significantly reduced the recurrence rate of bladder cancer and colorectal cancer in cancer patients (R).

Animal Studies:

L. rhamnosus has been shown to decrease the incidence of colon tumors and precancerous lesions in experimental animals as well as in human cells (R), and possess antitumor effects in animal models of bladder cancer (R).

L. plantarum enhances the anti-tumor immune response and delays tumor formation in mice with intestinal adenocarcinoma (R), and exhibits anti-colorectal cancer activities (R).

Long-term administration of L. plantarum is effective against breast cancer in rats (R,R), and inhibits the development of rat colon carcinogenesis (R).

L. casei  decreased cell migration and invasion of colorectal cancer cells (R,R), inhibited human and mouse colon cancer cell growth, and resulted in an 80% reduction in tumor volume of treated mice (R).

L. casei  delayed and suppressed tumor growth in mice with breast cancer, both when it was administered preventively and as a treatment. L. casei  further reduced tumor vascularity and lung metastasis, and prolonged survival (R,R,R).

Similarly, L. casei  decreased breast tumor volume and tumor vascularity in rats (R).

L. salivarius suppresses colon carcinogenesis (R), and inhibits oral cancer growth in rats (R).

L. delbrueckii  ssp. bulgaricus inhibits intestinal carcinogenesis in rats, ear-duct tumors in rats, and tracheal carcinogenesis in hamsters (R). This probiotic was also reported to inhibit the growth of sarcoma (R), leukemia, plasmacytoma, adenocarcinoma, melanosarcoma, and spontaneous tumors in mice (R).

L. acidophilus alters the cytokine production in tumor-bearing mice into a Th1 protective pattern, favorable to anti-tumor immunity (R).

L. acidophilus suppressed colon tumor incidence, tumor multiplicity, and reduced tumor size in mice (R).

Oral administration of L. acidophilus increased mouse survival (R), decreased tumor growth and increased lymphocyte proliferation in mice with breast tumors (R).

L. acidophilus reduced tumor volume growth by 50.3 %, reduced the severity of colonic carcinogenesis, and enhanced cancer cell death in mice (R).

L. helveticus inhibits the development of fibrosarcoma (R) and delays the development of breast tumors in mice (R).

Dietary B. longum significantly inhibited colon and liver and small intestinal tumors in male rats. In female rats, dietary supplementation also suppressed mammary carcinogenesis (R).

B. longum inhibits colorectal tumors in mice (R) and rats (R,R).

B. animalis ssp. lactis decreased the mean number and size of tumors in mice with colitis-associated cancer (R).

The synbiotic combination of carbohydrate ‘resistant starch‘ and B. animalis ssp. lactis protects against the development of colorectal cancer (CRC) in rats (R,R).

Heat-inactivated C. butyricum displays antitumor activity against sarcoma in mice (R) and inhibits the metastasis of melanoma by stimulating natural killer (NK) cell cytotoxic activity (R).

Furthermore, in mice, co-treatment with C. butyricum and B. subtilis inhibits the development of colorectal cancer (R).

An antitumor molecule derived from L. brevis inhibits colon adenocarcinoma cell viability and the growth of these cells in mice (R).

Mice with fibrosarcoma, treated by S. thermophilus were protected against this tumor when re-challenged. Additionally, spleen T-lymphocytes from cured animals could effectively transfer the antitumor activity to recipients transplanted with the tumor (R).

P. freudenreichii is able to kill colon cancer cells in rats (R).

62) Probiotics Could Reduce Toxins and Carcinogens in the Gut

In a cell-based study, Lactobacillus rhamnosus GG can bind to mold toxins that cause leaky gut and inflammation, thus prevent the negative effects of mold toxins on the gut cell (R, R2).

In rats, Lactobaccillus and other lactic acid bacteria can protect the gut and liver cells from cancer-causing chemicals that are found in foods like heterocyclic amines (R, R).

Probiotics can also reduce harm from aflatoxin, a mold toxin that is a potent live carcinogen in rats (R). In addition, probiotics can reduce biomarker of liver cancer risk in humans (R).


Most probiotics are safe. However, care should be taken when administering probiotics to severely ill or immunocompromised patients. There have been rare incidents of sepsis, endocarditis, and liver abscess during the use of Lactobacilli; additionally, fungemia has been reported with the use of S. boulardii, primarily in patients with severe comorbidities (R).

The most common side effects of probiotics are constipation, flatulence, hiccups, nausea, infection, and rash (R).

Some probiotic bacteria can produce biogenic amines: L. brevis and L. lactis can produce tyramine and putrescine (R,R,R). S. thermophilus can produce low amounts of histamine and tyramine (R). L. reuteri is able to produce histamine (R,R).

In rare cases S. cerevisiae may induce allergic responses (R).

B. bifidum cell-surface biopolymers (BPs) can interact selectively with human serum thyroid peroxidase (TPO) and thyroglobulin (Tg) autoantibodies (anti-TPO and anti-Tg, respectively). There is a possibility that Bifidobacteria play a role in the pathogenesis of autoimmune thyroid diseases (ATD) in those with a genetic predisposition to ATD (R).


Probiotic products can be formulated as capsules, tablets, powders (which are regulated as a dietary supplement), and a food ingredient (e.g., yogurts, kefirs) (R).

L. acidophilus and B. longum can survive and adhere better to the gastric mucosa than S. thermophilus and B. infantis/adolescentis/bifidum (R).

L. acidophilus can survive at pH ≥3 after 3h, and L. rhamnosus can survive 4h incubation at pH 2.5. The viability of several strains of Bifidobacterium was maintained for ~3h in the pH range of 1.5–3.0. On the other hand, L. delbrueckii and S. thermophilus do not readily survive stomach acidity (R).

To overcome the inability of some probiotics to survive, microencapsulated or coated probiotic strains have been developed (R).

Furthermore, even though some viable probiotic strains do not survive gastric transit, their dead forms remain beneficial. These nonviable probiotics are now known as ‘paraprobiotics’ or ‘ghost probiotics’. Non-viable probiotics can ameliorate the anti-inflammatory response in rats with colitis, protect against Candida, or exert antiproliferative and proapoptotic effects on cancer cells (R).

Each probiotic species comes in many different strains. Some of the properties of each species may be strain-specific or vary between strains. You can find the information about each strain in the reference.

Further Reading

For technical information, check individual probiotic chapters:

Buy Probiotic Supplements

About the Author

Biljana Novkovic - PHD (ECOLOGICAL GENETICS) - Writer at Selfhacked

Dr. Biljana Novkovic, PhD


Biljana received her PhD from Hokkaido University.

Before joining SelfHacked, she was a research scientist with extensive field and laboratory experience. She spent 4 years reviewing the scientific literature on supplements, lab tests and other areas of health sciences. She is passionate about releasing the most accurate science & health information available on topics, and she's meticulous when writing and reviewing articles to make sure the science is sound. She believes that SelfHacked has the best science that is also layperson-friendly on the web.

Click here to subscribe


1 Star2 Stars3 Stars4 Stars5 Stars
(4 votes, average: 5.00 out of 5)

FDA Compliance

The information on this website has not been evaluated by the Food & Drug Administration or any other medical body. We do not aim to diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition.